|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:G797833 |
| 產(chǎn)品名稱:GSK 2033 |
| 產(chǎn)品CAS:1221277-90-2 |
| 規(guī)格含量:50mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
G797833 |
| 名稱: |
GSK 2033 |
| 別名: |
2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide |
| CAS號: |
1221277-90-2 |
| 分子式: |
C??H??F?NO?S |
| 分子量: |
591.66 |
| 種類: |
Standards; Molecular Biology; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
GSK 2033 is a potent LXR antagonist. |
| 參考文獻(xiàn) |
|
|
|
|